JCRファーマ株式会社 · Pharmaceutical · FY ends Mar
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | Medipal Holdings Co., Ltd. | 29,131,000 | 23.83% | ¥16.6B | ¥583M |
| 2 | 日本マスタートラスト信託銀行株式会社 | 9,273,000 | 7.58% | ¥5.3B | ¥185M |
| 3 | Future Brain Co., Ltd. | 8,711,000 | 7.12% | ¥5.0B | ¥174M |
| 4 | 野村信託銀行株式会社 | 5,498,000 | 4.49% | ¥3.1B | ¥110M |
| 5 | 株式会社日本カストディ銀行 | 5,169,000 | 4.22% | ¥2.9B | ¥103M |
| 6 | Kissei Pharmaceutical Co., Ltd. | 4,918,000 | 4.02% | ¥2.8B | ¥98.4M |
| 7 | Mochida Pharmaceutical Co., Ltd. | 2,200,000 | 1.80% | ¥1.3B | ¥44.0M |
| 8 | ゴールドマン・サックス証券株式会社BNYM | 1,527,000 | 1.24% | ¥868M | ¥30.5M |
| 9 | 吉村 光司 | 1,500,000 | 1.22% | ¥852M | ¥30.0M |
| 10 | JCRファーマ従業員持株会 | 1,489,000 | 1.21% | ¥846M | ¥29.8M |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| Toru Ashida | Representative Director | 770,369 | ¥438M | — |
| 薗田 啓之 | Representative Director | 78,365 | ¥44.5M | — |
| アンドレア スペッチAndrea Spezzi | Director | 60,000 | ¥34.1M | — |
| 檜山 義雄 | Director | 53,611 | ¥30.5M | — |
| 芦田 信 | Founder | 246,900 | ¥140M | — |
| 末綱 隆 | Director | 3,900 | ¥2.2M | — |
| 林 裕子 | Director | 3,900 | ¥2.2M | — |
| 跡見 裕 | Director | 3,900 | ¥2.2M | — |
| フィリップ フォシェPhilippe Fauchet | Director | 3,900 | ¥2.2M | — |
| 浅野 敏雄 | Director | — | — | — |
| マークデュノワイエMarcDunoyer | Director | 3,900 | ¥2.2M | — |
| 依田 俊英 | Director | — | — | — |
| 大泉 和正 | Audit & Supervisory Board Member | 14,472 | ¥8.2M | — |
| 三津家 正之 | Audit & Supervisory Board Member | — | — | — |
| 深山 美弥 | Audit & Supervisory Board Member | — | — | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Mar 2026 | ¥568 | ¥17.87 | 31.8x | ¥20.0 | 129,686,000 |
| FY ending Mar 2025 | ¥568 | ¥-38.43 | — | ¥20.0 | 129,686,000 |
| FY ending Mar 2024 | ¥860 | ¥44.13 | 19.5x | ¥20.0 | 129,686,000 |
| FY ending Mar 2023 | ¥1,414 | ¥30.35 | 46.6x | ¥20.0 | 129,686,000 |
| FY ending Mar 2022 | ¥2,251 | ¥117.26 | 19.2x | ¥22.0 | 129,686,000 |
| FY ending Mar 2021 | ¥3,583 | ¥55.81 | 64.2x | ¥25.5 | 129,686,000 |
| FY ending Mar 2020 | ¥9,419 | ¥86.89 | 108.4x | ¥32.0 | 32,421,000 |
| FY ending Mar 2019 | ¥6,517 | ¥120.68 | 54.0x | ¥30.0 | 32,421,000 |
| FY ending Mar 2018 | ¥6,072 | ¥98.73 | 61.5x | ¥26.0 | 32,421,000 |
| FY ending Mar 2017 | ¥2,470 | ¥58.95 | 41.9x | ¥22.0 | 32,421,000 |